US Stock MarketDetailed Quotes

Benitec Biopharma (BNTC)

Watchlist
  • 12.830
  • +0.710+5.86%
Close Jan 22 16:00 ET
  • 12.830
  • 0.0000.00%
Post 20:01 ET
434.45MMarket Cap-11.77P/E (TTM)

Benitec Biopharma (BNTC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
-3K
1K
Gross profit
0
3K
-107.14%-1K
Operating expense
69.28%9.8M
85.70%41.77M
215.74%17.18M
145.85%10.19M
24.31%8.61M
-1.41%5.79M
17.40%22.49M
19.38%5.44M
-5.71%4.14M
23.15%6.93M
Selling and administrative expenses
191.61%6.43M
235.28%23.43M
562.13%13.48M
166.67%4.21M
93.97%3.54M
42.23%2.21M
9.51%6.99M
48.50%2.04M
28.50%1.58M
-2.09%1.82M
-General and administrative expense
191.61%6.43M
235.28%23.43M
562.13%13.48M
166.67%4.21M
93.97%3.54M
42.23%2.21M
9.51%6.99M
48.50%2.04M
28.50%1.58M
-2.09%1.82M
Research and development costs
-6.00%3.37M
17.45%18.33M
5.21%3.7M
133.05%5.98M
-0.59%5.07M
-19.06%3.59M
22.19%15.61M
10.23%3.51M
-18.98%2.57M
35.66%5.1M
Other operating expenses
----
----
----
----
----
----
---108K
--0
---3K
----
Operating profit
-69.28%-9.8M
-85.70%-41.77M
-209.59%-17.18M
-146.03%-10.19M
-24.30%-8.61M
1.41%-5.79M
-17.87%-22.49M
-21.93%-5.55M
4.61%-4.14M
-23.48%-6.93M
Net non-operating interest income expense
67.38%1.01M
263.50%3.29M
12.61%1.04M
20,675.00%823K
13,816.67%823K
10,166.67%604K
2,839.39%904K
11,600.00%920K
42.86%-4K
33.33%-6K
Non-operating interest income
----
----
----
----
--823K
----
----
----
----
----
Non-operating interest expense
----
----
----
----
----
----
----
----
-42.86%4K
-33.33%6K
Total other finance cost
-67.38%-1.01M
-263.50%-3.29M
-12.61%-1.04M
-20,675.00%-823K
----
-10,166.67%-604K
-2,839.39%-904K
---920K
--4K
----
Other net income (expense)
-235.16%-173K
440.61%562K
92.39%-7K
108.21%11K
218.52%430K
272.97%128K
63.17%-165K
10.68%-92K
-173.47%-134K
-35.10%135K
Gain on sale of security
-195.70%-89K
-282.05%-71K
91.94%119K
109.32%11K
-294.70%-294K
266.07%93K
109.33%39K
369.57%62K
-140.82%-118K
-4.43%151K
Special income (charges)
----
--764K
--0
--0
--764K
----
--0
--0
--0
--0
-Less:Other special charges
----
---764K
--0
----
---764K
----
----
----
----
----
Other non- operating income (expenses)
-340.00%-84K
35.78%-131K
18.18%-126K
----
-150.00%-40K
294.44%35K
-580.00%-204K
-92.50%-154K
---16K
-132.00%-16K
Income before tax
-77.21%-8.97M
-74.32%-37.92M
-242.10%-16.15M
-118.60%-9.35M
-8.22%-7.36M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
Income tax
Net income
-77.21%-8.97M
-74.32%-37.92M
-242.10%-16.15M
-118.60%-9.35M
-8.22%-7.36M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
Net income continuous Operations
-77.21%-8.97M
-74.32%-37.92M
-242.10%-16.15M
-118.60%-9.35M
-8.22%-7.36M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
Minority interest income
Net income attributable to the parent company
-77.21%-8.97M
-74.32%-37.92M
-242.10%-16.15M
-118.60%-9.35M
-8.22%-7.36M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
619K
0
0
0
Net income attributable to common stockholders
-77.21%-8.97M
-69.50%-37.92M
-242.10%-16.15M
-118.60%-9.35M
-8.22%-7.36M
23.03%-5.06M
-14.35%-22.37M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
Basic earnings per share
-22.22%-0.22
13.93%-1.05
-281.82%-0.42
-4.35%-0.24
87.50%-0.33
94.10%-0.18
91.36%-1.22
95.85%-0.11
91.39%-0.23
20.96%-2.64
Diluted earnings per share
-22.22%-0.22
13.93%-1.05
-281.82%-0.42
-4.35%-0.24
87.50%-0.33
94.10%-0.18
91.36%-1.22
95.85%-0.11
91.39%-0.23
20.96%-2.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 0-3K1K
Gross profit 03K-107.14%-1K
Operating expense 69.28%9.8M85.70%41.77M215.74%17.18M145.85%10.19M24.31%8.61M-1.41%5.79M17.40%22.49M19.38%5.44M-5.71%4.14M23.15%6.93M
Selling and administrative expenses 191.61%6.43M235.28%23.43M562.13%13.48M166.67%4.21M93.97%3.54M42.23%2.21M9.51%6.99M48.50%2.04M28.50%1.58M-2.09%1.82M
-General and administrative expense 191.61%6.43M235.28%23.43M562.13%13.48M166.67%4.21M93.97%3.54M42.23%2.21M9.51%6.99M48.50%2.04M28.50%1.58M-2.09%1.82M
Research and development costs -6.00%3.37M17.45%18.33M5.21%3.7M133.05%5.98M-0.59%5.07M-19.06%3.59M22.19%15.61M10.23%3.51M-18.98%2.57M35.66%5.1M
Other operating expenses ---------------------------108K--0---3K----
Operating profit -69.28%-9.8M-85.70%-41.77M-209.59%-17.18M-146.03%-10.19M-24.30%-8.61M1.41%-5.79M-17.87%-22.49M-21.93%-5.55M4.61%-4.14M-23.48%-6.93M
Net non-operating interest income expense 67.38%1.01M263.50%3.29M12.61%1.04M20,675.00%823K13,816.67%823K10,166.67%604K2,839.39%904K11,600.00%920K42.86%-4K33.33%-6K
Non-operating interest income ------------------823K--------------------
Non-operating interest expense ---------------------------------42.86%4K-33.33%6K
Total other finance cost -67.38%-1.01M-263.50%-3.29M-12.61%-1.04M-20,675.00%-823K-----10,166.67%-604K-2,839.39%-904K---920K--4K----
Other net income (expense) -235.16%-173K440.61%562K92.39%-7K108.21%11K218.52%430K272.97%128K63.17%-165K10.68%-92K-173.47%-134K-35.10%135K
Gain on sale of security -195.70%-89K-282.05%-71K91.94%119K109.32%11K-294.70%-294K266.07%93K109.33%39K369.57%62K-140.82%-118K-4.43%151K
Special income (charges) ------764K--0--0--764K------0--0--0--0
-Less:Other special charges -------764K--0-------764K--------------------
Other non- operating income (expenses) -340.00%-84K35.78%-131K18.18%-126K-----150.00%-40K294.44%35K-580.00%-204K-92.50%-154K---16K-132.00%-16K
Income before tax -77.21%-8.97M-74.32%-37.92M-242.10%-16.15M-118.60%-9.35M-8.22%-7.36M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M
Income tax
Net income -77.21%-8.97M-74.32%-37.92M-242.10%-16.15M-118.60%-9.35M-8.22%-7.36M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M
Net income continuous Operations -77.21%-8.97M-74.32%-37.92M-242.10%-16.15M-118.60%-9.35M-8.22%-7.36M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M
Minority interest income
Net income attributable to the parent company -77.21%-8.97M-74.32%-37.92M-242.10%-16.15M-118.60%-9.35M-8.22%-7.36M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M
Preferred stock dividends
Other preferred stock dividends 00000619K000
Net income attributable to common stockholders -77.21%-8.97M-69.50%-37.92M-242.10%-16.15M-118.60%-9.35M-8.22%-7.36M23.03%-5.06M-14.35%-22.37M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M
Basic earnings per share -22.22%-0.2213.93%-1.05-281.82%-0.42-4.35%-0.2487.50%-0.3394.10%-0.1891.36%-1.2295.85%-0.1191.39%-0.2320.96%-2.64
Diluted earnings per share -22.22%-0.2213.93%-1.05-281.82%-0.42-4.35%-0.2487.50%-0.3394.10%-0.1891.36%-1.2295.85%-0.1191.39%-0.2320.96%-2.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More